These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4601672)

  • 1. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.
    Steuber CP; Fernbach DJ; Starling KA; Falletta JM
    Cancer Chemother Rep; 1974; 58(3):417-9. PubMed ID: 4601672
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary evaluation of cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in acute leukemia of children.
    Freedman MH; Finklestein JZ; Gilchrist GS; Hammond GD; Higgins GR; Hyman CB; Shore NA; Williams KO; Karon MR
    Cancer Chemother Rep; 1969 Oct; 53(5):299-303. PubMed ID: 5270583
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).
    Albo V; Movassaghi N; Sitarz AL; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(6):1097-102. PubMed ID: 769949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
    Rosenstock JG; Donaldson MH
    Cancer Treat Rep; 1976 Mar; 60(3):265-7. PubMed ID: 1063066
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological purging of bone marrow with reference to autografting.
    Santos GW; Colvin OM
    Clin Haematol; 1986 Feb; 15(1):67-83. PubMed ID: 2421955
    [No Abstract]   [Full Text] [Related]  

  • 8. Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
    Sitarz AL; Albo V; Movassaghi N; Karon M; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(5):989-94. PubMed ID: 1106848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute leukemia with 5-azacytidine (NSC-102816).
    McCredie KB; Bodey GP; Burgess MA; Gutterman JU; Rodriguez V; Sullivan MP; Freireich EJ
    Cancer Chemother Rep; 1973; 57(3):319-23. PubMed ID: 4127393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of leukemia].
    Hennemann HH
    MMW Munch Med Wochenschr; 1976 Mar; 118(10):285-90. PubMed ID: 817149
    [No Abstract]   [Full Text] [Related]  

  • 12. Varying prednisone dosage in remission induction of previously untreated childhood leukemia.
    Leikin SL; Brubaker C; Hartmann JR; Murphy ML; Wolff JA; Perrin E
    Cancer; 1968 Mar; 21(3):346-51. PubMed ID: 5237296
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies of leukocyte metabolism. V. NAD and ATP in isolated leukocytes and erythrocytes in human leukemias under the effect of cytostatic compounds C73, busulfan and cyclophosphamide].
    Ehrhart H; Hörmann W; Scheffel G; Armbröster E
    Klin Wochenschr; 1970 Feb; 48(4):204-9. PubMed ID: 4331706
    [No Abstract]   [Full Text] [Related]  

  • 14. Daunorubicin (NSC-83142) in advanced childhood leukemia.
    Jaffe N; Traggis DG; Das L
    Cancer Chemother Rep; 1974; 58(5 Pt 1):661-5. PubMed ID: 4529663
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of resistance to L-asparaginase in human leukemia.
    Canellos GP; Haskell CM
    Recent Results Cancer Res; 1970; 33():188-93. PubMed ID: 4949162
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of nandrolone phenylpropionate (NSC-23162e) on the bone marrow suppression caused by cyclophosphamide (NSC-26271): a clinical trial.
    Burn JI; Cooke WM
    Cancer Chemother Rep; 1974; 58(6):867-70. PubMed ID: 4615786
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged infusion of arabinosyl cytosine in childhood leukemia.
    Wang JJ; Selawry OS; Vietti TJ; Bodey GP
    Cancer; 1970 Jan; 25(1):1-6. PubMed ID: 5262259
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose melphalan with or without marrow transplantation: a study of dose-effect in patients with refractory and/or relapsed acute leukemias.
    Maraninchi D; Pico JL; Hartmann O; Gastaut JA; Kamioner D; Hayat M; Mascret B; Beaujean F; Sebahoun G; Novakovitch G
    Cancer Treat Rep; 1986 Apr; 70(4):445-8. PubMed ID: 3516394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
    Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
    Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.